Diarrhea leading to severe dehydration, renal insufficiency, and electrolyte abnormalities is uncommon and reversible with treatment interruption and/or discontinuation. Results from ongoing Phase 2 Study 6201 suggest that antidiarrheal prophylaxis decreases the incidence and severity of diarrhea.